Naman Julka-Anderson and Jo McNamara catch up with Dr. Veronica Dell’Acqua and Prof. Cihan Gani about incredible careers, the hypothesis testing programme (HTP) and MR-adaptive dose escalated radiotherapy in rectal cancer (MARS).

 

To use this podcast as CPD, look at these reflection points: 

1) consider the benefits of the MR Linac consortium in progressing MR-adaptive radiotherapy.

2) reflect on the challenges people with rectal cancer face with current radiotherapy workflows.

3) consider the benefits of organ sparing within the rectal cancer pathway.

Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.

Links from podcast:

MR-Linac Consortium Website: https://mrlconsortium.org

Elekta Focus Article on MR Linac: https://www.elekta.com/focus/first-of-its-kind-program-to-reinforce-mr-guided-radiation-therapy-evidence-base/

Evolution of the MOMENTUM Study for Evidence-Based Implementation of MR-Guided Radiotherapy Using the 1.5 Tesla MR-Linac: https://www.redjournal.org/article/S0360-3016(23)06346-0/fulltext

Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05415-9/fulltext

Patient-Reported Outcomes of Rectal Cancer Patients Treated on a 1.5T MR-Linac within the MOMENTUM Study: https://www.redjournal.org/article/S0360-3016(23)05720-6/fulltext

Optimising the MR-Linac as a standard treatment modality: https://onlinelibrary.wiley.com/doi/10.1002/jmrs.712

Interim Toxicity Analysis From the Randomized HERMES Trial of 2- and 5-Fraction Magnetic Resonance Imaging–Guided Adaptive Prostate Radiation Therapy: https://www.redjournal.org/article/S0360-3016(23)07949-X/fulltext

Development of prostate bed delineation consensus guidelines for MRI-guided radiotherapy and assessment of its impact on interobserver variability: https://www.redjournal.org/article/S0360-3016(23)07848-3/fulltext

Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors: Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors - Radiotherapy and Oncology(thegreenjournal.com)

Please like and subscribe to Rad Chat on your podcast library.

Our links:

Link Tree:https://linktr.ee/radchat 

Facebook:https://www.facebook.com/RadChatPodcast/ 

Instagram:https://www.instagram.com/rad__chat/ 

LinkedIn:https://uk.linkedin.com/company/radtalk 

Tik Tok:https://www.tiktok.com/@rad_chat 

Twitter:https://twitter.com/rad__chat?lang=en 

YouTube: https://www.youtube.com/@radchat2259

Music and jingle credits: Dr. Ben Potts and Adam Cooke.